Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7713941 Tricyclic nucleosides or nucleotides as therapeutic agents

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Kandasamy Sakthivel0

Phillip Dan Cook0

Vasanthankumar Rajappan0

Vivek K. Rajwanshi0

Yi Jin0

Marija Prhavc0

Gregory Ewing0

John Lambert0

Date of Patent

May 11, 2010

0

Patent Application Number

105689170

Date Filed

August 27, 2004

0

Patent Citations Received

US Patent 12084473 β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

0

US Patent 11707480 Highly active compounds against COVID-19

0

US Patent 11780844 Compounds and methods for treatment of viral infections

US Patent 11851438 1′-cyano nucleoside analogs and methods for treatment of viral infections

0

US Patent 11903953 Remdesivir treatment methods

0

US Patent 11926645 Compounds and methods for treatment of viral infections

0

US Patent 11939347 1′-cyano nucleoside analogs and uses thereof

0

US Patent 11975017 Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections

0

...

Patent Primary Examiner

Shaojia Anna Jiang

0

Patent abstract

Nucelosides and nucleotides containing a tricyclic base portion thereof are useful for treating infectious diseases and proliferative disorders, such as viral infections or cancer respectively.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7713941 Tricyclic nucleosides or nucleotides as therapeutic agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool